FLT3 and acute myeloid leukemia: Next generation sequencing exhibited superior comprehensiveness in FLT3 genetic alteration assessment, providing additional information in regions not examined by fragment analysis, which may further improve personalized, targeted therapy in acute myeloid leukemia.